Potent adenylate cyclase agonist forskolin restores myoprotective effects of ischemic preconditioning in rat hearts after myocardial infarction

Annals of Thoracic Surgery

Volumn 74, Issue 4, 2002, Pages 1213-1218

  Mieno, Shigetoshi ^a   Horimoto, Hitoshi ^a,b   Watanabe, Fusao ^a   Nakai, Yasunari ^a   Furuya, Eisuke ^a   Sasaki, Shinjiro ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b Department of Thoracic and Cardiovascular Surgery ^*  (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ADRENALIN; BETA 2 ADRENERGIC RECEPTOR; FORSKOLIN; MESSENGER RNA; NORADRENALIN;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENYLATE CYCLASE; ANIMALS; CATECHOLAMINES; ENZYME ACTIVATION; FORSKOLIN; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION;

EID: 0036799728     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)03841-9     Document Type: Conference Paper

References (20)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
2. Downey JM. Ischemic preconditioning. Nature's own cardioprotective intervention. Trans Cardiovasc Med 1992;2:170-5.
3. Horimoto H, Saltman AE, Gaudett GR, Krukenkamp IB. Nitric oxide-generating beta-adrenergic blocker Nipradilol preserves postischemic cardiac function. Ann Thorac Surg 1999;68:844-9.
4. Peralta C, Bartrons R, Riera L. Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol 2000;279:G163-71.
5. Du ZY, Hicks M, Winlaw D, Spratt P, Macdonald P. Ischemic preconditioning enhances donor lung preservation in the rat. J Heart Lung Transplant 1996;15:1258-67.
6. Yabe K, Ishihita H, Tanonaka K, Takeo S. Pharmacological preconditioning induced by beta-adrenergic stimulation is mediated by activation of protein kinase C. J Cardiovasc Pharmacol 1998;32:962-8.
7. Lochner A, Genade S, Tromp E, Podzuweit T, Moolman JA. Ischemic preconditioning and the beta-adrenergic signal transduction pathway. Circulation 1999;100:958-66.
8. Sandhu R, Thomas U, Diaz RJ. Effects of ischemic preconditioning of the myocardium on cAMP. Circ Res 1996;78:137-47.
9. Lefkowitz RJ, Rockman HA, Koch WJ. Cathecholamines, cardiac beta-adrenergic receptors, and heart failure. Circulation 2000;101:1634-7.
10. Bristow MR. Changes in myocardial and vascular receptors in heart failure. J Am Coll Cardiol 1993;22(Suppl A):61A.
11. Xiao RP, Cheng H, Zhou YY. Recent advances in cardiac β2-adrenergic signal transduction. Circ Res 1999;85:1092-100.
12. Selye H, Bajusz E, Grasso S, Mendell P. Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology 1960;11:398-407.
13. Kingston RE, Chomczynski P, Sacchi N. Guanidinium methods for total RNA preparation. In: Ausubel FM, Brent R, Kingston RE, Moore DD, et al, eds. Current protocols in molecular biology. New York: Wiley, 1992:4.2.4-8.
14. Moolman JA, Genade S, Tromp E, Lochner A. A comparison between ischemic preconditioning and anti-adrenergic interventions: cAMP, energy metabolism and functional recovery. Basic Res Cardiol 1996;78:137-47.
15. Antonio RL, Brodde OE, Veldhuisen DJ, Scholtens E, Crijns HJGM, Gilst WH. β-adrenoceptor density in chronic infarcted myocardium: a subtype specific decrease of β-adrenoceptor density. Int J Cardiol 2000;72:137-41.
16. Okruhlicova L, Ravingerova T, Pancza D, Tribulova N, Styk J, Stetka R. Activation of adenylate cyclase system in the preconditioned rat heart. Physiol Res 2000;49:251-9.
17. ATP channels contribute to the cardioprotection of preconditioning independent of anaesthetics in rabbit hearts. J Mol Cell Cardiol 1997;29:1267-76.
18. Steinberg SF. The molecular basis for distinct β-adrenergic receptor subtype actions in cardiomyocytes. Circ Res 1999;85:1101-11.
19. Hajjar RJ, Muller FU, Schmitz W, Schnabel P, Bohm M. Molecular aspects of adrenergic signal transduction in cardiac failure. J Mol Med 1998;76:747-55.
20. Seamon KB, Daly JW, Metzger H, Souza NJ, Reden J. Structure-activity relationship for activation of adenylate cyclase by the diterpene forskolin and its derivatives. J Med Chem 1983;26:436-9.